Up a level |
Alhassan, Yussif, Twimukye, Adelline, Malaba, Thoko, Orrell, Catherine, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Lamorde, Mohammed, Kambugu, Andrew, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye et al (show 1 more authors)
(2020)
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda.
BMC Public Health, 20 (1).
1883-.
Alhassan, Yussif, Twimukye, Adelline, Malaba, Thoko, Orrell, Catherine, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Lamorde, Mohammed, Kambugu, Andrew, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye et al (show 1 more authors)
(2020)
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda.
BMC HEALTH SERVICES RESEARCH, 20 (1).
705-.
Waitt, Catriona ORCID: 0000-0003-0134-5855, Orrell, Catherine, Walimbwa, Stephen, Singh, Yashna, Kintu, Kenneth, Simmons, Bryony, Kaboggoza, Julian ORCID: 0000-0001-9510-0474, Sihlangu, Mary, Coombs, Julie-Anne, Malaba, Thoko et al (show 13 more authors)
(2019)
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
PLOS MEDICINE, 16 (9).
e1002895-.